CNSP - CNS Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 326.46%
52 Week High 35.6900
52 Week Low 33.6500
50-Day Moving Average 34.0720
200-Day Moving Average 34.1170

Share Statistics

Avg Vol (3 month) 3130.77k
Avg Vol (10 day) 3191.46k
Shares Outstanding 516.45M
Float 6.49M
% Held by Insiders 160.54%
% Held by Institutions 10.00%
Shares Short (Dec 30, 2019) 4144.58k
Short Ratio (Dec 30, 2019) 41.98
Short % of Float (Dec 30, 2019) 42.57%
Short % of Shares Outstanding (Dec 30, 2019) 40.88%
Shares Short (prior month Nov 28, 2019) 466.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-7.98M
Diluted EPS (ttm)-0.6370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)630.11k
Total Cash Per Share (mrq)0.04
Total Debt (mrq)300k
Total Debt/Equity (mrq)138,888.89
Current Ratio (mrq)1.00
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.24M
Levered Free Cash Flow (ttm)N/A